How much is Aclaris Therapeutics worth in 2026?

Aclaris Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Aclaris Therapeutics raised?

Aclaris Therapeutics has raised N/A in total funding across 2 funding rounds.

Aclaris Therapeutics

Drug Discovery

Aclaris Therapeutics valuation and funding history | Last updated: March 25, 2025 | 2 funding rounds

Current Valuation

N/A

As of March 25, 2025

Total Funding Raised

N/A

Across 2 rounds

Last Round

PIPE

$100.0M

Last Funding

Mar 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 25, 2025	PIPE	$100.0M	N/A	-
April 25, 2022	PIPE	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Aclaris Therapeutics is currently valued at N/A as of March 25, 2025.

Track Aclaris Therapeutics Valuation Updates

Get notified when Aclaris Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Aclaris Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Aclaris Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Aclaris Therapeutics Worth in 2026?

Aclaris Therapeutics is a leading private company in the Drug Discovery sector. Track Aclaris Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Aclaris Therapeutics Valuation is Determined

Private company valuations like Aclaris Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.